Wisdomtree Gr Hdg Eq (DXGE) 24.45 $DXGE Surprise ETF

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wisdomtree Gr Hdg Eq (DXGE) 24.45 $DXGE

Surprise ETF Winners & Losers Post ECB Easing
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 11:58AM CST
ECB expands QE and lowered several main interest rates; did this leave a desirable impact on the ETF world?
HEDJ: 50.59 (+0.68), VGK: 46.34 (+0.68), GREK: 7.01 (+0.13), DXGE: 24.45 (+0.37), QDEU: 48.48 (+1.97), FXE: 107.82 (+0.08)

Health of Euro Zone Recovers: ETFs to Watch
Zacks Equity Research - Zacks Investment Research - Thu Nov 26, 1:00PM CST
ETFs to bet on the four-and-a-half year high growth in Euro zone business activity in November.
HEDJ: 50.59 (+0.68), EUSC: 23.13 (+0.36), DXGE: 24.45 (+0.37)

11 Most Popular Currency Hedged ETFs
Sweta Killa - Zacks Investment Research - Mon Nov 23, 7:13AM CST
Here is a guide to 11 most popular currency hedged ETFs.
DXJ: 39.66 (+1.87), HEDJ: 50.59 (+0.68), HEWJ: 23.70 (+1.14), DBEU: 24.65 (+0.29), DBEF: 25.24 (+0.49), IHDG: 25.85 (+0.43), DBJP: 31.49 (+1.49), DXGE: 24.45 (+0.37), HEFA: 23.72 (+0.46), HEZU: 23.32 (+0.28), HEWG: 22.19 (+0.34)

3 European ETFs Rebounding Sharply
Zacks Equity Research - Zacks Investment Research - Wed Oct 28, 11:23AM CDT
These Europe-related ETFs were some of the biggest beneficiaries of indication of more quantitative easing by ECB.
HEDJ: 50.59 (+0.68), EUSC: 23.13 (+0.36), DXGE: 24.45 (+0.37), FXE: 107.82 (+0.08), HEWG: 22.19 (+0.34)

German ETFs Hurt as Business Confidence Falls
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 12:18PM CDT
German ETFs took a beating yesterday as reports indicated a fall in business confidence for the first time in four months.
EWG: 24.03 (+0.38), FGM: 34.96 (+0.76), DXGE: 24.45 (+0.37), HEWG: 22.19 (+0.34)

European ETF Boom Leads To Record Inflows
ETFtrends.com - ETF Trends - Thu Oct 15, 4:00PM CDT
Exchange traded funds are not just gaining wider acceptance in the U.S. The investment vehicle is making headway across many global markets. For instance, Howie Li, co-head of Canvas at ETF Securities, anticipates further growth for European-listed...
HEDJ: 50.59 (+0.68), EWG: 24.03 (+0.38), FEZ: 30.91 (+0.42), DBGR: 21.66 (+0.33), DXGE: 24.45 (+0.37), DBEZ: 23.60 (+0.40), EZU: 32.05 (+0.42), HEZU: 23.32 (+0.28), HEWG: 22.19 (+0.34)

Three German ETFs Vulnerable to Volkswagen Scandal
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 10:12AM CDT
Given the allegations surrounding the VW scandal, we highlight three Germany-focused ETFs, which are highly exposed to German automobile stocks.
EWG: 24.03 (+0.38), DBGR: 21.66 (+0.33), DXGE: 24.45 (+0.37), GM: 30.13 (+0.47)

Dovish Draghi Drives Up These European ETFs
Zacks Equity Research - Zacks Investment Research - Fri Sep 04, 10:57AM CDT
These Europe-related ETFs were some of the biggest beneficiaries of ECB’s indication of more quantitative easing to boost the sagging Euro zone economy.
DBGR: 21.66 (+0.33), DBEZ: 23.60 (+0.40), DXGE: 24.45 (+0.37), EUO: 24.45 (-0.10), HEWG: 22.19 (+0.34)

Follow Goldman with These European ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 11:00AM CDT
With the subsiding Greek debt default drama, investors can play the potential European growth story via these top-ranked ETFs.
HEDJ: 50.59 (+0.68), DXGE: 24.45 (+0.37), HEZU: 23.32 (+0.28)

As Greece Risks Fade, Overweight Europe ETFs Back in Play
ETFtrends.com - ETF Trends - Wed Jul 22, 6:30AM CDT
With Greece paying back creditors and volatility dissipating, investors may want to revisit the international investment theme through Eurozone-related exchange traded funds. Goldman Sachs (NYSE: GS) has now upgraded its three-month view on...
SPXU: 24.79 (-0.25), HEDJ: 50.59 (+0.68), SPXS: 13.16 (-0.14), SDS: 17.15 (-0.12), HEWP: 17.85 (+0.23), DBGR: 21.66 (+0.33), DXGE: 24.45 (+0.37), DBEZ: 23.60 (+0.40), HEZU: 23.32 (+0.28), HEWI: 16.66 (+0.15), HEWG: 22.19 (+0.34)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading